康弘药业：10月28日召开董事会会议

Group 1 - The core point of the article is that Kanghong Pharmaceutical announced an adjustment to its organizational structure during its board meeting held on October 28, 2025 [1] - For the first half of 2025, Kanghong Pharmaceutical's revenue composition was 99.97% from the pharmaceutical manufacturing industry and 0.03% from other businesses [1] - As of the report, Kanghong Pharmaceutical has a market capitalization of 29.9 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation [1] - A new "slow bull" market pattern is emerging, indicating a shift in market dynamics [1]